definiens: within the meaning of the Private Securities Litigation ReformAct of 1995 . These statements, which include statements related to the potential development and commercialization ofantibody - based cancer immunotherapies against the [COMPANY] - discovered immune checkpoint targets, potentialmilestone and royalty payments, and that the collaboration validates [COMPANY] ’s predictive discovery infrastructure, include words such as and and describe opinions aboutfuture events . These forward - looking statements involve known and unknown risks and uncertainties that may cause theactual results, performance or achievements of [COMPANY] to be materially different from any future results, performanceor achievements expressed or implied by such forward - looking statements . Some of these risks and other factors arediscussed in the section of [COMPANY] ’s Annual Report on Form 20 - F for the year ended December 31,2012 as filed with the Securities and Exchange Commission . In addition, any forward - looking statements representCompugen ’s views only as of the date of this release and should not be relied upon as representing its views as of anysubsequent date . [COMPANY] does not assume any obligation to update any forward - looking statements unless requiredby law